338 related articles for article (PubMed ID: 4474187)
1. Human parathyroid hormone. Immunological characterization of antibodies against a glandular extract and the synthetic amino-terminal fragments 1-12 and 1-34 and their use in the determination of immunoreactive hormone in human sera.
Fischer JA; Binswanger U; Dietrich FM
J Clin Invest; 1974 Dec; 54(6):1382-94. PubMed ID: 4474187
[TBL] [Abstract][Full Text] [Related]
2. Immunoheterogeneity of parathyroid hormone in venous effluent serum from hyperfunctioning parathyroid glands.
Flueck JA; Di Bella FP; Edis AJ; Kehrwald JM; Arnaud CD
J Clin Invest; 1977 Dec; 60(6):1367-75. PubMed ID: 915003
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a high-affinity antiserum specific for the amino-terminal sequence of human parathyroid hormone.
Vieira JG; Federico P; Keutmann HT; Neer RM
Braz J Med Biol Res; 1987; 20(6):721-9. PubMed ID: 2458156
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of parathyroid hormone. Clinical and physiologic implications.
Silverman R; Yalow RS
J Clin Invest; 1973 Aug; 52(8):1958-71. PubMed ID: 4719672
[TBL] [Abstract][Full Text] [Related]
5. A radioimmunoassay for human parathyroid hormone utilizing a goat anti-bovine PTH serum.
Mallette LE
Acta Endocrinol (Copenh); 1981 Feb; 96(2):215-21. PubMed ID: 7468103
[TBL] [Abstract][Full Text] [Related]
6. Carboxyl-terminal fragments of human parathyroid hormone in parathyroid tumors: unique new source of immunogens for the production of antisera potentially useful in the radioimmunoassay of parathyroid hormone in human serum.
Di Bella FP; Gilkinson JB; Flueck J; Arnaud CD
J Clin Endocrinol Metab; 1978 Apr; 46(4):604-12. PubMed ID: 755044
[TBL] [Abstract][Full Text] [Related]
7. Development of sequence specific radioimmunoassay of human parathyroid hormone and its use in the diagnosis of hyperparathyroidism.
Gautvik KM; Teig V; Halvorsen JF; Arnesen E; Myhre L; Heimann P; Tollman R
Scand J Clin Lab Invest; 1979 Sep; 39(5):469-78. PubMed ID: 574982
[TBL] [Abstract][Full Text] [Related]
8. Peripheral metabolism of parathyroid hormone in patients with primary hyperparathyroidism as judged by immunological and biological studies.
Gautvik KM; Gordeladze JO; Moxheim E; Gautvik VT
Eur Surg Res; 1984; 16 Suppl 2():41-54. PubMed ID: 6723731
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of the antibovine parathyroid hormone serum 211/32 to synthetic fragments of human parathyroid hormone.
Mallette LE
J Clin Endocrinol Metab; 1980 Jan; 50(1):201-3. PubMed ID: 7350182
[TBL] [Abstract][Full Text] [Related]
10. Immunological studies on parathyroid hormone: characterization of antisera against synthetic 1-34 human parathyroid hormone and evidence that position 30 in human parathyroid hormone is aspartic acid.
Visser TJ; Buurman CJ; Birkenhäger JC
J Endocrinol; 1977 Sep; 74(3):461-6. PubMed ID: 925571
[TBL] [Abstract][Full Text] [Related]
11. Bovine parathyroid hormone-(41-84), a hormone fragment with desirable properties for use as radioligand.
Mallette LE; Bradley WA
J Lab Clin Med; 1981 Dec; 98(6):886-95. PubMed ID: 7310228
[TBL] [Abstract][Full Text] [Related]
12. Effects of parathyroid hormone and the synthetic 1-34 amino-terminal fragment in rats and dogs.
Stevenson RW; Parsons JA
J Endocrinol; 1983 Apr; 97(1):21-30. PubMed ID: 6842124
[TBL] [Abstract][Full Text] [Related]
13. Immunological properties of synthetic human parathyroid hormone: effect of deamidation at position 76.
Gleed JH; Hendy GN; Kimura T; Sakakibara S; O'Riordan JL
Bone Miner; 1987 Aug; 2(5):375-82. PubMed ID: 2464379
[TBL] [Abstract][Full Text] [Related]
14. Human parathyroid hormone: synthesis and chemical, biological, and immunological evaluation of the carboxyl-terminal region.
Rosenblatt M; Segre GV; Tregear GW; Shepard GL; Tyler GA; Potts JT
Endocrinology; 1978 Sep; 103(3):978-84. PubMed ID: 744126
[TBL] [Abstract][Full Text] [Related]
15. Immunochemiluminometric assay with two monoclonal antibodies against the N-terminal sequence of human parathyroid hormone.
Gao P; Schmidt-Gayk H; Dittrich K; Nolting B; Maier A; Roth HJ; Seemann O; Reichel H; Ritz E; Schilling T
Clin Chim Acta; 1996 Feb; 245(1):39-59. PubMed ID: 8646814
[TBL] [Abstract][Full Text] [Related]
16. Production and characterization of antisera to synthetic 1-34 human parathyroid hormone fragments: possible implications for the correctness of proposed structures.
Visser TJ; Buurman CJ; Birkenhäger JC
Acta Endocrinol (Copenh); 1979 Jan; 90(1):90-102. PubMed ID: 760361
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoassay for the middle region of human parathyroid hormone: comparison of two radioiodinated synthetic peptides.
Sharp ME; Marx SJ
Clin Chim Acta; 1985 Jan; 145(1):59-68. PubMed ID: 3978821
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunoassay for the middle region of human parathyroid hormone: studies with a radioiodinated synthetic peptide.
Marx SJ; Sharp ME; Krudy A; Rosenblatt M; Mallette LE
J Clin Endocrinol Metab; 1981 Jul; 53(1):76-84. PubMed ID: 7240381
[TBL] [Abstract][Full Text] [Related]
19. Solution structures of human parathyroid hormone fragments hPTH(1-34) and hPTH(1-39) and bovine parathyroid hormone fragment bPTH(1-37).
Marx UC; Adermann K; Bayer P; Forssmann WG; Rösch P
Biochem Biophys Res Commun; 2000 Jan; 267(1):213-20. PubMed ID: 10623601
[TBL] [Abstract][Full Text] [Related]
20. Binding of intact parathyroid hormone to rat osteosarcoma cells: major contribution of binding sites for the carboxyl-terminal region of the hormone.
Rao LG; Murray TM
Endocrinology; 1985 Oct; 117(4):1632-8. PubMed ID: 2992916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
